Aromatase inhibitors in breast cancer: a review of cost considerations and cost effectiveness. [electronic resource]
- PharmacoEconomics 2006
- 215-32 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1170-7690
10.2165/00019053-200624030-00002 doi
Aromatase Inhibitors--economics Breast Neoplasms--drug therapy Cost-Benefit Analysis Drug Costs Drug Therapy, Combination Female Humans